ABOUT PCG
OUR MISSION
The Proton Collaborative Group (PCG) was founded in 2009 by a group of radiation oncologists whose primary mission was to improve the survival outcomes of cancer patients and the quality of life for affected individuals. These oncologists strongly believed that collaborating to develop new research protocols and sharing those results across multiple treatment centers would best serve their mission.
NON-PROFIT
CORPORATION
Originally launched to serve one private company’s treatment centers in 2009, PCG has evolved into an independent 501(c)3 non-profit corporation that currently provides proton therapy-specific clinical research oversight to nine independent treatment centers and institutional members across the US.
OUR RESEARCH
To date, PCG research data has been used in close to 50 scientific manuscripts, posters and conference presentations. PCG has been represented at 20 industry conferences and appeared in seven distinct peer-reviewed journals over the past three years. Having partnered with nine treatment centers to collect data, there are more than 5,800 patients in the PCG registry.
PCG BOARD OF DIRECTORS
Andrew Chang, MD
Vice President/Treasurer
The California Protons Therapy Cancer Treatment Center
Dr. Carlos Vargas
Member at Large
Mayo Clinic AZ
Dr. Minesh Mehta
Member at Large
Miami Cancer Institute
George Laramore, PhD, MD
Secretary
Seattle Cancer Care Alliance Proton Center
Dr. Michael Chuong
Member at Large
Miami Cancer Institute
PCG STAFF
WANT TO LEARN MORE?
Contact Proton Collaborative Group (PCG) today and a member of our highly trained staff will reach out to discuss any questions you may have.
